×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

Sharing the spoils

Sharing the spoils
Comment E-mail Print Share
First Published: Thu, May 05 2011. 11 11 PM IST
Updated: Thu, May 05 2011. 11 11 PM IST
In the lucrative US pharmaceutical market, generic and patent holders of drugs have increasingly chosen to settle patent challenge disputes, than to fight them in court.
Also see | Sharing the spoils(PDF)
Generic companies, including Indian firms that have done such settlements, benefit because it provides certainty of income for their efforts and lowers litigation costs. Innovator companies get a little more breathing space, before their cash cow products turn generic.
But the US FederalTrade Commission believes these settlements limit access to affordable medicines and wants them blocked.
Graphic by Yogesh Kumar/Mint
We welcome your comments at marktomarket@livemint.com
Comment E-mail Print Share
First Published: Thu, May 05 2011. 11 11 PM IST